<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34360957</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>15</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>30</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Progressive Mitochondrial SOD1<sup>G93A</sup> Accumulation Causes Severe Structural, Metabolic and Functional Aberrations through OPA1 Down-Regulation in a Mouse Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8194</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22158194</ELocationID><Abstract><AbstractText>In recent years, the "non-autonomous motor neuron death" hypothesis has become more consolidated behind amyotrophic lateral sclerosis (ALS). It postulates that cells other than motor neurons participate in the pathology. In fact, the involvement of the autonomic nervous system is fundamental since patients die of sudden death when they become unable to compensate for cardiorespiratory arrest. Mitochondria are thought to play a fundamental role in the physiopathology of ALS, as they are compromised in multiple ALS models in different cell types, and it also occurs in other neurodegenerative diseases. Our study aimed to uncover mitochondrial alterations in the sympathoadrenal system of a mouse model of ALS, from a structural, bioenergetic and functional perspective during disease instauration. We studied the adrenal chromaffin cell from mutant SOD1<sup>G93A</sup> mouse at pre-symptomatic and symptomatic stages. The mitochondrial accumulation of the mutated SOD1<sup>G93A</sup> protein and the down-regulation of optic atrophy protein-1 (OPA1) provoke mitochondrial ultrastructure alterations prior to the onset of clinical symptoms. These changes affect mitochondrial fusion dynamics, triggering mitochondrial maturation impairment and cristae swelling, with increased size of cristae junctions. The functional consequences are a loss of mitochondrial membrane potential and changes in the bioenergetics profile, with reduced maximal respiration and spare respiratory capacity of mitochondria, as well as enhanced production of reactive oxygen species. This study identifies mitochondrial dynamics regulator OPA1 as an interesting therapeutic target in ALS. Additionally, our findings in the adrenal medulla gland from presymptomatic stages highlight the relevance of sympathetic impairment in this disease. Specifically, we show new SOD1<sup>G93A</sup> toxicity pathways affecting cellular energy metabolism in non-motor neurons, which offer a possible link between cell specific metabolic phenotype and the progression of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xe9;ndez-L&#xf3;pez</LastName><ForeName>Iago</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-3428-1109</Identifier><AffiliationInfo><Affiliation>Instituto Te&#xf3;filo Hernando and Departamento de Farmacolog&#xed;a y Terap&#xe9;utica, Facultad de Medicina, Universidad Aut&#xf3;noma de Madrid (UAM), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sancho-Bielsa</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><Identifier Source="ORCID">0000-0003-3521-5477</Identifier><AffiliationInfo><Affiliation>Departamento de Ciencias M&#xe9;dicas, Facultad de Medicina, Universidad de Castilla-La Mancha (UCLM), 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9137-0637</Identifier><AffiliationInfo><Affiliation>Department of Physiology &amp; Medical Physics, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FutureNeuro SFI Research Centre for Chronic and Rare Neurological Diseases, RCSI University of Medicine and Health Sciences, D02 YN77 Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Antonio G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Instituto Te&#xf3;filo Hernando and Departamento de Farmacolog&#xed;a y Terap&#xe9;utica, Facultad de Medicina, Universidad Aut&#xf3;noma de Madrid (UAM), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pad&#xed;n</LastName><ForeName>Juan Fernando</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Instituto Te&#xf3;filo Hernando and Departamento de Farmacolog&#xed;a y Terap&#xe9;utica, Facultad de Medicina, Universidad Aut&#xf3;noma de Madrid (UAM), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ciencias M&#xe9;dicas, Facultad de Medicina, Universidad de Castilla-La Mancha (UCLM), 13005 Ciudad Real, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SAF2013-44108-P</GrantID><Agency>Ministerio de Econom&#xed;a, Industria y Competitividad, Gobierno de Espa&#xf1;a</Agency><Country/></Grant><Grant><GrantID>2016-78892-R</GrantID><Agency>Ministerio de Econom&#xed;a, Industria y Competitividad, Gobierno de Espa&#xf1;a</Agency><Country/></Grant><Grant><GrantID>FPI BES-2014-069005</GrantID><Agency>Ministerio de Econom&#xed;a, Industria y Competitividad, Gobierno de Espa&#xf1;a</Agency><Country/></Grant><Grant><GrantID>EEBB-I-17-12697</GrantID><Agency>Ministerio de Econom&#xed;a, Industria y Competitividad, Gobierno de Espa&#xf1;a</Agency><Country/></Grant><Grant><GrantID>EEBB-I-18-13033</GrantID><Agency>Ministerio de Econom&#xed;a, Industria y Competitividad, Gobierno de Espa&#xf1;a</Agency><Country/></Grant><Grant><GrantID>17/CDA/4708</GrantID><Acronym>SFI_</Acronym><Agency>Science Foundation Ireland</Agency><Country>Ireland</Country></Grant><Grant><GrantID>16/RC/3948</GrantID><Acronym>SFI_</Acronym><Agency>Science Foundation Ireland</Agency><Country>Ireland</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D020558">GTP Phosphohydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C498809">Opa1 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000311" MajorTopicYN="N">Adrenal Glands</DescriptorName><QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019439" MajorTopicYN="N">Chromaffin Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015536" MajorTopicYN="N">Down-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020558" MajorTopicYN="N">GTP Phosphohydrolases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053078" MajorTopicYN="N">Membrane Potential, Mitochondrial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">OPA1</Keyword><Keyword MajorTopicYN="N">SOD1G93A</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">chromaffin cell</Keyword><Keyword MajorTopicYN="N">mitochondrial dysfunction</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>7</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34360957</ArticleId><ArticleId IdType="pmc">PMC8347639</ArticleId><ArticleId IdType="doi">10.3390/ijms22158194</ArticleId><ArticleId IdType="pii">ijms22158194</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Charcot J.M. Deux cas d&#x2019;atrophie musculaire progressive avec lesions de la substance grise et des faisceaux anterolateraux de la moelle epiniere. Arch. Pathol. Norm. Pathol. 1869;2:744&#x2013;760.</Citation></Reference><Reference><Citation>Nguyen H.P., van Broeckhoven C., van der Zee J. ALS Genes in the Genomic Era and their Implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto M.C., Gurney M.E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 1994;145:1271&#x2013;1279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887498</ArticleId><ArticleId IdType="pubmed">7992831</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A., Nakano I., Kurland L.T., Mulder D.W., Holley P.W., Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1984;43:471&#x2013;480. doi: 10.1097/00005072-198409000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00002</ArticleId><ArticleId IdType="pubmed">6540800</ArticleId></ArticleIdList></Reference><Reference><Citation>Dal Canto M.C., Gurney M.E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS) Brain Res. 1995;676:25&#x2013;40. doi: 10.1016/0006-8993(95)00063-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(95)00063-V</ArticleId><ArticleId IdType="pubmed">7796176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Pardo C.A., Borchelt D.R., Lee M.K., Copeland N.G., Jenkins N.A., Sisodia S.S., Cleveland D.W., Price D.L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong J., Xu Z. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J. Neurosci. Off. J. Soc. Neurosci. 1998;18:3241&#x2013;3250. doi: 10.1523/JNEUROSCI.18-09-03241.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.18-09-03241.1998</ArticleId><ArticleId IdType="pmc">PMC6792665</ArticleId><ArticleId IdType="pubmed">9547233</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Rognoni F., van Duijn W., Verspaget H.W., Haasdijk E.D., Holstege J.C. CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol. 2001;102:293&#x2013;305. doi: 10.1007/s004010100399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010100399</ArticleId><ArticleId IdType="pubmed">11603803</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Mitochondriopathy in Parkinson disease and amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2006;65:1103&#x2013;1110. doi: 10.1097/01.jnen.0000248541.05552.c4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248541.05552.c4</ArticleId><ArticleId IdType="pubmed">17146283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffoli R., Biagioni F., Busceti C.L., Gaglione A., Ryskalin L., Gambardella S., Frati A., Fornai F. Neurons other than motor neurons in motor neuron disease. Histol. Histopathol. 2017;32:1115&#x2013;1123. doi: 10.14670/HH-11-895.</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/HH-11-895</ArticleId><ArticleId IdType="pubmed">28397197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Lee H., Lee J.H., Kwon D.Y., Genovesio A., Fenistein D., Ogier A., Brondani V., Grailhe R. Dimerization, oligomerization, and aggregation of human amyotrophic lateral sclerosis copper/zinc superoxide dismutase 1 protein mutant forms in live cells. J. Biol. Chem. 2014;289:15094&#x2013;15103. doi: 10.1074/jbc.M113.542613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.542613</ArticleId><ArticleId IdType="pmc">PMC4031559</ArticleId><ArticleId IdType="pubmed">24692554</ArticleId></ArticleIdList></Reference><Reference><Citation>Pansarasa O., Rossi D., Berardinelli A., Cereda C. Amyotrophic lateral sclerosis and skeletal muscle: An update. Mol. Neurobiol. 2014;49:984&#x2013;990. doi: 10.1007/s12035-013-8578-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8578-4</ArticleId><ArticleId IdType="pubmed">24198230</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M., Ferri A., Carri M.T. Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications. Antioxid. Redox Signal. 2008;10:405&#x2013;443. doi: 10.1089/ars.2007.1760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2007.1760</ArticleId><ArticleId IdType="pubmed">18370853</ArticleId></ArticleIdList></Reference><Reference><Citation>Musaro A. Understanding ALS: New therapeutic approaches. FEBS J. 2013;280:4315&#x2013;4322. doi: 10.1111/febs.12087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12087</ArticleId><ArticleId IdType="pubmed">23217177</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Goedee H.S., Westeneng H.J., Nijboer T.C.W., van den Berg L.H. Is it accurate to classify ALS as a neuromuscular disorder? Expert Rev. Neurother. 2020;20:895&#x2013;906. doi: 10.1080/14737175.2020.1806061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2020.1806061</ArticleId><ArticleId IdType="pubmed">32749157</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash Y., Sitty M. Non-Motor Symptoms of Amyotrophic Lateral Sclerosis: A Multi-Faceted Disorder. J. Neuromuscul. Dis. 2021 doi: 10.3233/JND-210632.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JND-210632</ArticleId><ArticleId IdType="pubmed">34024773</ArticleId></ArticleIdList></Reference><Reference><Citation>Silani V., Ludolph A., Fornai F. The emerging picture of ALS: A multisystem, not only a &#x201c;motor neuron disease&#x201d;. Arch Ital. Biol. 2017;155:99&#x2013;109. doi: 10.12871/00039829201741.</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201741</ArticleId><ArticleId IdType="pubmed">29405027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y.H., Parsadanian A.S., Andreeva A., Snider W.D., Elliott J.L. Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J. Neurosci. Off. J. Soc. Neurosci. 2000;20:660&#x2013;665. doi: 10.1523/JNEUROSCI.20-02-00660.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-02-00660.2000</ArticleId><ArticleId IdType="pmc">PMC6772423</ArticleId><ArticleId IdType="pubmed">10632595</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino M.M., Schneider C., Caroni P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. Off. J. Soc. Neurosci. 2002;22:4825&#x2013;4832. doi: 10.1523/JNEUROSCI.22-12-04825.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pmc">PMC6757755</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Weber M. The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve. 2001;24:564&#x2013;573. doi: 10.1002/mus.1042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.1042</ArticleId><ArticleId IdType="pubmed">11268031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsitkanou S., Della Gatta P.A., Russell A.P. Skeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALS. Front. Physiol. 2016;7:403. doi: 10.3389/fphys.2016.00403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2016.00403</ArticleId><ArticleId IdType="pmc">PMC5020084</ArticleId><ArticleId IdType="pubmed">27679581</ArticleId></ArticleIdList></Reference><Reference><Citation>Chida K., Sakamaki S., Takasu T. Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis. J. Neurol. 1989;236:127&#x2013;130. doi: 10.1007/BF00314326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00314326</ArticleId><ArticleId IdType="pubmed">2709061</ArticleId></ArticleIdList></Reference><Reference><Citation>Druschky A., Spitzer A., Platsch G., Claus D., Feistel H., Druschky K., Hilz M.J., Neundorfer B. Cardiac sympathetic denervation in early stages of amyotrophic lateral sclerosis demonstrated by 123I-MIBG-SPECT. Acta Neurol. Scand. 1999;99:308&#x2013;314. doi: 10.1111/j.1600-0404.1999.tb00681.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb00681.x</ArticleId><ArticleId IdType="pubmed">10348161</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltadzhieva R., Gurevich T., Korczyn A.D. Autonomic impairment in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2005;18:487&#x2013;493. doi: 10.1097/01.wco.0000183114.76056.0e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000183114.76056.0e</ArticleId><ArticleId IdType="pubmed">16155429</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccione E.A., Sletten D.M., Staff N.P., Low P.A. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:676&#x2013;679. doi: 10.1002/mus.24457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24457</ArticleId><ArticleId IdType="pmc">PMC4362936</ArticleId><ArticleId IdType="pubmed">25211238</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandinov B., Korczyn A.D., Rabinowitz R., Nefussy B., Drory V.E. Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis. Auton. Neurosci. Basic Clin. 2011;159:84&#x2013;89. doi: 10.1016/j.autneu.2010.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2010.09.002</ArticleId><ArticleId IdType="pubmed">20869331</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita A., Koike Y., Takahashi A., Hirayama M., Murakami N., Sobue G. Relationship between respiratory failure and plasma noradrenaline levels in amyotrophic lateral sclerosis. Clin. Auton. Res. Off. J. Clin. Auton. Res. Soc. 1997;7:173&#x2013;177. doi: 10.1007/BF02267978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02267978</ArticleId><ArticleId IdType="pubmed">9292242</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandinov B., Grigoriadis N.C., Touloumi O., Drory V.E., Offen D., Korczyn A.D. Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:424&#x2013;433. doi: 10.3109/21678421.2013.780622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.780622</ArticleId><ArticleId IdType="pubmed">23607704</ArticleId></ArticleIdList></Reference><Reference><Citation>Oey P.L., Vos P.E., Wieneke G.H., Wokke J.H., Blankestijn P.J., Karemaker J.M. Subtle involvement of the sympathetic nervous system in amyotrophic lateral sclerosis. Muscle Nerve. 2002;25:402&#x2013;408. doi: 10.1002/mus.10049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10049</ArticleId><ArticleId IdType="pubmed">11870718</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Gallardo E., de Pascual R., Fernandez-Morales J.C., Arranz-Tagarro J.A., Maroto M., Nanclares C., Gandia L., de Diego A.M., Padin J.F., Garcia A.G. Depressed excitability and ion currents linked to slow exocytotic fusion pore in chromaffin cells of the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Am. J. Physiol. Cell Physiol. 2015;308:C1&#x2013;C19. doi: 10.1152/ajpcell.00272.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00272.2014</ArticleId><ArticleId IdType="pubmed">25377090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Hayashi H., Kato S., Hayashi M., Tanabe H., Oda M. Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J. Neurol. Sci. 1994;124:45&#x2013;55. doi: 10.1016/0022-510X(94)90009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90009-4</ArticleId><ArticleId IdType="pubmed">7931421</ArticleId></ArticleIdList></Reference><Reference><Citation>Vukosavic S., Dubois-Dauphin M., Romero N., Przedborski S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 1999;73:2460&#x2013;2468. doi: 10.1046/j.1471-4159.1999.0732460.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1999.0732460.x</ArticleId><ArticleId IdType="pubmed">10582606</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Vande Velde C. Misfolded SOD1 and ALS: Zeroing in on mitochondria. Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis. 2012;13:333&#x2013;340. doi: 10.3109/17482968.2012.648645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.648645</ArticleId><ArticleId IdType="pubmed">22471903</ArticleId></ArticleIdList></Reference><Reference><Citation>Deitch J.S., Alexander G.M., Bensinger A., Yang S., Jiang J.T., Heiman-Patterson T.D. Phenotype of transgenic mice carrying a very low copy number of the mutant human G93A superoxide dismutase-1 gene associated with amyotrophic lateral sclerosis. PLoS ONE. 2014;9:e99879. doi: 10.1371/journal.pone.0099879.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099879</ArticleId><ArticleId IdType="pmc">PMC4063781</ArticleId><ArticleId IdType="pubmed">24945277</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Haasdijk E.D., Grashorn J.A., Hawkins R., van Duijn W., Verspaget H.W., London J., Holstege J.C. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 2000;7:623&#x2013;643. doi: 10.1006/nbdi.2000.0299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0299</ArticleId><ArticleId IdType="pubmed">11114261</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith E.F., Shaw P.J., De Vos K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2017 doi: 10.1016/j.neulet.2017.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.06.052</ArticleId><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Bendotti C., Calvaresi N., Chiveri L., Prelle A., Moggio M., Braga M., Silani V., De Biasi S. Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 2001;191:25&#x2013;33. doi: 10.1016/S0022-510X(01)00627-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00627-X</ArticleId><ArticleId IdType="pubmed">11676989</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.M., Jung C., Xu Z. ALS-associated mutant SOD1G93A causes mitochondrial vacuolation by expansion of the intermembrane space and by involvement of SOD1 aggregation and peroxisomes. BMC Neurosci. 2003;4:16. doi: 10.1186/1471-2202-4-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-4-16</ArticleId><ArticleId IdType="pmc">PMC169170</ArticleId><ArticleId IdType="pubmed">12864925</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Jung C., Higgins C., Levine J., Kong J. Mitochondrial degeneration in amyotrophic lateral sclerosis. J. Bioenerg. Biomembr. 2004;36:395&#x2013;399. doi: 10.1023/B:JOBB.0000041774.12654.e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:JOBB.0000041774.12654.e1</ArticleId><ArticleId IdType="pubmed">15377878</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampelt H., Zerbes R.M., van der Laan M., Pfanner N. Role of the mitochondrial contact site and cristae organizing system in membrane architecture and dynamics. Biochim. Biophys. Acta Mol. Cell Res. 2017;1864:737&#x2013;746. doi: 10.1016/j.bbamcr.2016.05.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2016.05.020</ArticleId><ArticleId IdType="pubmed">27614134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioakeimidis F., Ott C., Kozjak-Pavlovic V., Violitzi F., Rinotas V., Makrinou E., Eliopoulos E., Fasseas C., Kollias G., Douni E. A splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in mice. PLoS ONE. 2014;9:e104237. doi: 10.1371/journal.pone.0104237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104237</ArticleId><ArticleId IdType="pmc">PMC4128653</ArticleId><ArticleId IdType="pubmed">25111180</ArticleId></ArticleIdList></Reference><Reference><Citation>Darshi M., Mendiola V.L., Mackey M.R., Murphy A.N., Koller A., Perkins G.A., Ellisman M.H., Taylor S.S. ChChd3, an inner mitochondrial membrane protein, is essential for maintaining crista integrity and mitochondrial function. J. Biol. Chem. 2011;286:2918&#x2013;2932. doi: 10.1074/jbc.M110.171975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.171975</ArticleId><ArticleId IdType="pmc">PMC3024787</ArticleId><ArticleId IdType="pubmed">21081504</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S.E., Daum G. Lipids of mitochondria. Prog. Lipid Res. 2013;52:590&#x2013;614. doi: 10.1016/j.plipres.2013.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2013.07.002</ArticleId><ArticleId IdType="pubmed">24007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Shidoji Y., Hayashi K., Komura S., Ohishi N., Yagi K. Loss of molecular interaction between cytochrome c and cardiolipin due to lipid peroxidation. Biochem. Biophys. Res. Commun. 1999;264:343&#x2013;347. doi: 10.1006/bbrc.1999.1410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1999.1410</ArticleId><ArticleId IdType="pubmed">10529366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkinezos I.G., Bacman S.R., Hernandez D., Oca-Cossio J., Arias L.J., Perez-Pinzon M.A., Bradley W.G., Moraes C.T. Cytochrome c association with the inner mitochondrial membrane is impaired in the CNS of G93A-SOD1 mice. J. Neurosci. Off. J. Soc. Neurosci. 2005;25:164&#x2013;172. doi: 10.1523/JNEUROSCI.3829-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3829-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725219</ArticleId><ArticleId IdType="pubmed">15634778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnert M., Zerbes R.M., Davies K.M., Muhleip A.W., Rampelt H., Horvath S.E., Boenke T., Kram A., Perschil I., Veenhuis M., et al. Central role of Mic10 in the mitochondrial contact site and cristae organizing system. Cell Metab. 2015;21:747&#x2013;755. doi: 10.1016/j.cmet.2015.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.04.007</ArticleId><ArticleId IdType="pubmed">25955210</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J. Biology of mitochondria in neurodegenerative diseases. Prog. Mol. Biol. Transl. Sci. 2012;107:355&#x2013;415. doi: 10.1016/B978-0-12-385883-2.00005-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-385883-2.00005-9</ArticleId><ArticleId IdType="pmc">PMC3530202</ArticleId><ArticleId IdType="pubmed">22482456</ArticleId></ArticleIdList></Reference><Reference><Citation>Napoletano F., Baron O., Vandenabeele P., Mollereau B., Fanto M. Intersections between Regulated Cell Death and Autophagy. Trends Cell Biol. 2019;29:323&#x2013;338. doi: 10.1016/j.tcb.2018.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2018.12.007</ArticleId><ArticleId IdType="pubmed">30665736</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrice J.R., Gregory-Evans C.Y., Shaw C.A. Necroptosis in amyotrophic lateral sclerosis and other neurological disorders. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:347&#x2013;353. doi: 10.1016/j.bbadis.2016.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2016.11.025</ArticleId><ArticleId IdType="pubmed">27902929</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannella C.A. Structure and dynamics of the mitochondrial inner membrane cristae. Biochim. Biophys. Acta. 2006;1763:542&#x2013;548. doi: 10.1016/j.bbamcr.2006.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2006.04.006</ArticleId><ArticleId IdType="pubmed">16730811</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintana-Cabrera R., Mehrotra A., Rigoni G., Soriano M.E. Who and how in the regulation of mitochondrial cristae shape and function. Biochem. Biophys. Res. Commun. 2018;500:94&#x2013;101. doi: 10.1016/j.bbrc.2017.04.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.04.088</ArticleId><ArticleId IdType="pubmed">28438601</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke B., Cortassa S., Aon M.A. Mitochondrial ion channels: Gatekeepers of life and death. Physiology. 2005;20:303&#x2013;315. doi: 10.1152/physiol.00020.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiol.00020.2005</ArticleId><ArticleId IdType="pmc">PMC2739045</ArticleId><ArticleId IdType="pubmed">16174870</ArticleId></ArticleIdList></Reference><Reference><Citation>Frezza C., Cipolat S., Martins de Brito O., Micaroni M., Beznoussenko G.V., Rudka T., Bartoli D., Polishuck R.S., Danial N.N., De Strooper B., et al. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell. 2006;126:177&#x2013;189. doi: 10.1016/j.cell.2006.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.06.025</ArticleId><ArticleId IdType="pubmed">16839885</ArticleId></ArticleIdList></Reference><Reference><Citation>Cogliati S., Frezza C., Soriano M.E., Varanita T., Quintana-Cabrera R., Corrado M., Cipolat S., Costa V., Casarin A., Gomes L.C., et al. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell. 2013;155:160&#x2013;171. doi: 10.1016/j.cell.2013.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.08.032</ArticleId><ArticleId IdType="pmc">PMC3790458</ArticleId><ArticleId IdType="pubmed">24055366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulino R., Vicario N., Giunta M.A.S., Spoto G., Calabrese G., Vecchio M., Gulisano M., Leanza G., Parenti R. Neuromuscular Plasticity in a Mouse Neurotoxic Model of Spinal Motoneuronal Loss. Int. J. Mol. Sci. 2019;20:1500. doi: 10.3390/ijms20061500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20061500</ArticleId><ArticleId IdType="pmc">PMC6471664</ArticleId><ArticleId IdType="pubmed">30917493</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriques A., Pitzer C., Schneider A. Characterization of a novel SOD-1(G93A) transgenic mouse line with very decelerated disease development. PLoS ONE. 2010;5:e15445. doi: 10.1371/journal.pone.0015445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015445</ArticleId><ArticleId IdType="pmc">PMC2978730</ArticleId><ArticleId IdType="pubmed">21102999</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferri A., Coccurello R. What is &#x201c;Hyper&#x201d; in the ALS Hypermetabolism? Mediat. Inflamm. 2017;2017:7821672. doi: 10.1155/2017/7821672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7821672</ArticleId><ArticleId IdType="pmc">PMC5610793</ArticleId><ArticleId IdType="pubmed">29081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Millaruelo A.I., Sagarra M.R., Delicado E., Torres M., Miras-Portugal M.T. Enzymes and pathways of glucose utilization in bovine adrenal medulla. Mol. Cell. Biochem. 1986;70:67&#x2013;76. doi: 10.1007/BF00233804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00233804</ArticleId><ArticleId IdType="pubmed">3713707</ArticleId></ArticleIdList></Reference><Reference><Citation>Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: Implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 1999;46:787&#x2013;790. doi: 10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199911)46:5&lt;787::AID-ANA17&gt;3.0.CO;2-8</ArticleId><ArticleId IdType="pubmed">10553999</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann F.R., Manfredi G., Mawrin C., Beal M.F., Schon E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002;80:616&#x2013;625. doi: 10.1046/j.0022-3042.2001.00731.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0022-3042.2001.00731.x</ArticleId><ArticleId IdType="pubmed">11841569</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M., D&#x2019;Aurelio M., Gajewski C.D., Martushova K., Kiaei M., Beal M.F., Manfredi G. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633. doi: 10.1074/jbc.M203065200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M203065200</ArticleId><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>St-Pierre J., Buckingham J.A., Roebuck S.J., Brand M.D. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J. Biol. Chem. 2002;277:44784&#x2013;44790. doi: 10.1074/jbc.M207217200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M207217200</ArticleId><ArticleId IdType="pubmed">12237311</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa S., Brand M.D. Mitochondrial matrix reactive oxygen species production is very sensitive to mild uncoupling. Biochem. Soc. Trans. 2003;31:1300&#x2013;1301. doi: 10.1042/bst0311300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0311300</ArticleId><ArticleId IdType="pubmed">14641047</ArticleId></ArticleIdList></Reference><Reference><Citation>Sena L.A., Chandel N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell. 2012;48:158&#x2013;167. doi: 10.1016/j.molcel.2012.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2012.09.025</ArticleId><ArticleId IdType="pmc">PMC3484374</ArticleId><ArticleId IdType="pubmed">23102266</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand M.D. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. Exp. Gerontol. 2000;35:811&#x2013;820. doi: 10.1016/S0531-5565(00)00135-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0531-5565(00)00135-2</ArticleId><ArticleId IdType="pubmed">11053672</ArticleId></ArticleIdList></Reference><Reference><Citation>Plecita-Hlavata L., Jezek P. Integration of superoxide formation and cristae morphology for mitochondrial redox signaling. Int. J. Biochem. Cell Biol. 2016;80:31&#x2013;50. doi: 10.1016/j.biocel.2016.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2016.09.010</ArticleId><ArticleId IdType="pubmed">27640755</ArticleId></ArticleIdList></Reference><Reference><Citation>Estevez A.G., Crow J.P., Sampson J.B., Reiter C., Zhuang Y., Richardson G.J., Tarpey M.M., Barbeito L., Beckman J.S. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 1999;286:2498&#x2013;2500. doi: 10.1126/science.286.5449.2498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5449.2498</ArticleId><ArticleId IdType="pubmed">10617463</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005;74:563&#x2013;593. doi: 10.1146/annurev.biochem.72.121801.161647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., Goolsby H., Fontaine B.A., Lemay N., McKenna-Yasek D., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanton R.C. Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life. 2012;64:362&#x2013;369. doi: 10.1002/iub.1017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1017</ArticleId><ArticleId IdType="pmc">PMC3325335</ArticleId><ArticleId IdType="pubmed">22431005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sochor M., Gonzalez A.M., McLean P. Regulation of glucose metabolism in rat adrenal gland in alloxan-diabetes: The possible role of fructose 2,6-bisphosphate. Biochem. Biophys. Res. Commun. 1984;121:8&#x2013;13. doi: 10.1016/0006-291X(84)90680-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(84)90680-6</ArticleId><ArticleId IdType="pubmed">6547341</ArticleId></ArticleIdList></Reference><Reference><Citation>Maker H., Clarke D., Lajtha A. Intermediary metabolism of carbohydrates and amino acids. Basic Neurochem. 1976:279&#x2013;307.</Citation></Reference><Reference><Citation>Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain A J. Neurol. 2005;128:1686&#x2013;1706. doi: 10.1093/brain/awh503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh503</ArticleId><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S., Heath P.R., Kirby J., Wharton S.B., Cookson M.R., Menzies F.M., Banks R.E., Shaw P.J. Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways. J. Biol. Chem. 2003;278:6371&#x2013;6383. doi: 10.1074/jbc.M209915200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209915200</ArticleId><ArticleId IdType="pubmed">12475980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazmierczak B., Kuzma-Kozakiewicz M., Usarek E., Baranczyk-Kuzma A. Differences in glutathione S-transferase pi expression in transgenic mice with symptoms of neurodegeneration. Acta Biochim. Pol. 2011;58:621&#x2013;626. doi: 10.18388/abp.2011_2233.</Citation><ArticleIdList><ArticleId IdType="doi">10.18388/abp.2011_2233</ArticleId><ArticleId IdType="pubmed">22132373</ArticleId></ArticleIdList></Reference><Reference><Citation>Philbert M.A., Beiswanger C.M., Manson M.M., Green J.A., Novak R.F., Primiano T., Reuhl K.R., Lowndes H.E. Glutathione S-transferases and gamma-glutamyl transpeptidase in the rat nervous systems: A basis for differential susceptibility to neurotoxicants. Neurotoxicology. 1995;16:349&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">7566694</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundberg A.G., Nilsson R., Appelkvist E.L., Dallner G. Immunohistochemical localization of alpha and pi class glutathione transferases in normal human tissues. Pharmacol. Toxicol. 1993;72:321&#x2013;331. doi: 10.1111/j.1600-0773.1993.tb01658.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0773.1993.tb01658.x</ArticleId><ArticleId IdType="pubmed">8372055</ArticleId></ArticleIdList></Reference><Reference><Citation>Seredenina T., Nayernia Z., Sorce S., Maghzal G.J., Filippova A., Ling S.C., Basset O., Plastre O., Daali Y., Rushing E.J., et al. Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2016;97:95&#x2013;108. doi: 10.1016/j.freeradbiomed.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.05.016</ArticleId><ArticleId IdType="pubmed">27212019</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Wen J., Liu J., Li L. The roles of free radicals in amyotrophic lateral sclerosis: Reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 1999;13:2318&#x2013;2328. doi: 10.1096/fasebj.13.15.2318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.13.15.2318</ArticleId><ArticleId IdType="pubmed">10593879</ArticleId></ArticleIdList></Reference><Reference><Citation>Jomova K., Vondrakova D., Lawson M., Valko M. Metals, oxidative stress and neurodegenerative disorders. Mol. Cell Biochem. 2010;345:91&#x2013;104. doi: 10.1007/s11010-010-0563-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-010-0563-x</ArticleId><ArticleId IdType="pubmed">20730621</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S., Spencer D.M., Halloran M.A., Soo K.Y., Atkin J.D. Redox regulation in amyotrophic lateral sclerosis. Oxid. Med. Cell Longev. 2013;2013:408681. doi: 10.1155/2013/408681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/408681</ArticleId><ArticleId IdType="pmc">PMC3596916</ArticleId><ArticleId IdType="pubmed">23533690</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H., Yoon Y. Mitochondrial Membrane Dynamics-Functional Positioning of OPA1. Antioxidants. 2018;7:186. doi: 10.3390/antiox7120186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox7120186</ArticleId><ArticleId IdType="pmc">PMC6316456</ArticleId><ArticleId IdType="pubmed">30544804</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Dotto V., Fogazza M., Carelli V., Rugolo M., Zanna C. Eight human OPA1 isoforms, long and short: What are they for? Biochim. Biophys. Acta Bioenerg. 2018;1859:263&#x2013;269. doi: 10.1016/j.bbabio.2018.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbabio.2018.01.005</ArticleId><ArticleId IdType="pubmed">29382469</ArticleId></ArticleIdList></Reference><Reference><Citation>Rainbolt T.K., Lebeau J., Puchades C., Wiseman R.L. Reciprocal Degradation of YME1L and OMA1 Adapts Mitochondrial Proteolytic Activity during Stress. Cell Rep. 2016;14:2041&#x2013;2049. doi: 10.1016/j.celrep.2016.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.02.011</ArticleId><ArticleId IdType="pmc">PMC4785047</ArticleId><ArticleId IdType="pubmed">26923599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra P., Carelli V., Manfredi G., Chan D.C. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metab. 2014;19:630&#x2013;641. doi: 10.1016/j.cmet.2014.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2014.03.011</ArticleId><ArticleId IdType="pmc">PMC4018240</ArticleId><ArticleId IdType="pubmed">24703695</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarosh W., Monserrate J., Tong J.J., Tse S., Le P.K., Nguyen K., Brachmann C.B., Wallace D.C., Huang T. The molecular mechanisms of OPA1-mediated optic atrophy in Drosophila model and prospects for antioxidant treatment. PLoS Genet. 2008;4:e6. doi: 10.1371/journal.pgen.0040006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0040006</ArticleId><ArticleId IdType="pmc">PMC2174975</ArticleId><ArticleId IdType="pubmed">18193945</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari P., Song M., Dorn G.W., 2nd Dissociation of mitochondrial from sarcoplasmic reticular stress in Drosophila cardiomyopathy induced by molecularly distinct mitochondrial fusion defects. J. Mol. Cell. Cardiol. 2015;80:71&#x2013;80. doi: 10.1016/j.yjmcc.2014.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2014.12.018</ArticleId><ArticleId IdType="pmc">PMC4346473</ArticleId><ArticleId IdType="pubmed">25555803</ArticleId></ArticleIdList></Reference><Reference><Citation>Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal. 2002;14:879&#x2013;897. doi: 10.1016/S0898-6568(02)00053-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0898-6568(02)00053-0</ArticleId><ArticleId IdType="pubmed">12220615</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller-Rischart A.K., Pilsl A., Beaudette P., Patra M., Hadian K., Funke M., Peis R., Deinlein A., Schweimer C., Kuhn P.H., et al. The E3 ligase parkin maintains mitochondrial integrity by increasing linear ubiquitination of NEMO. Mol. Cell. 2013;49:908&#x2013;921. doi: 10.1016/j.molcel.2013.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.01.036</ArticleId><ArticleId IdType="pubmed">23453807</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M., Rodrigues V., Silvestre R., Gautier C., Weil R., Corti O., Estaquier J. NF-kappaB pathway controls mitochondrial dynamics. Cell Death Differ. 2016;23:89&#x2013;98. doi: 10.1038/cdd.2015.42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2015.42</ArticleId><ArticleId IdType="pmc">PMC4815975</ArticleId><ArticleId IdType="pubmed">26024391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004;27:723&#x2013;749. doi: 10.1146/annurev.neuro.27.070203.144244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.neuro.27.070203.144244</ArticleId><ArticleId IdType="pubmed">15217349</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.M., Jung C., Ding H., Xu Z. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci. Off. J. Soc. Neurosci. 2002;22:RC215. doi: 10.1523/JNEUROSCI.22-06-j0001.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-06-j0001.2002</ArticleId><ArticleId IdType="pmc">PMC6758252</ArticleId><ArticleId IdType="pubmed">11886899</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Warita H., Murakami T., Abe K., Iwata M. Ultrastructural study of mitochondria in the spinal cord of transgenic mice with a G93A mutant SOD1 gene. Acta Neuropathol. 2004;107:461&#x2013;474. doi: 10.1007/s00401-004-0837-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0837-z</ArticleId><ArticleId IdType="pubmed">15029445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahtoniemi T., Jaronen M., Keksa-Goldsteine V., Goldsteins G., Koistinaho J. Mutant SOD1 from spinal cord of G93A rats is destabilized and binds to inner mitochondrial membrane. Neurobiol. Dis. 2008;32:479&#x2013;485. doi: 10.1016/j.nbd.2008.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.08.010</ArticleId><ArticleId IdType="pubmed">18817872</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A., Arbel N., Da Cruz S., Ilieva H., Yamanaka K., Shoshan-Barmatz V., Cleveland D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasinelli P., Belford M.E., Lennon N., Bacskai B.J., Hyman B.T., Trotti D., Brown R.H., Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron. 2004;43:19&#x2013;30. doi: 10.1016/j.neuron.2004.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.06.021</ArticleId><ArticleId IdType="pubmed">15233914</ArticleId></ArticleIdList></Reference><Reference><Citation>Kira Y., Sato E.F., Inoue M. Association of Cu,Zn-type superoxide dismutase with mitochondria and peroxisomes. Arch. Biochem. Biophys. 2002;399:96&#x2013;102. doi: 10.1006/abbi.2001.2738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.2001.2738</ArticleId><ArticleId IdType="pubmed">11883908</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H., Almer G., Yamashita S., Guegan C., Nagai M., Xu Z., Sosunov A.A., McKhann G.M., 2nd, Przedborski S. Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model. Proc. Natl. Acad. Sci. USA. 2006;103:6025&#x2013;6030. doi: 10.1073/pnas.0509227103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0509227103</ArticleId><ArticleId IdType="pmc">PMC1458691</ArticleId><ArticleId IdType="pubmed">16595634</ArticleId></ArticleIdList></Reference><Reference><Citation>Medinas D.B., Rozas P., Martinez Traub F., Woehlbier U., Brown R.H., Bosco D.A., Hetz C. Endoplasmic reticulum stress leads to accumulation of wild-type SOD1 aggregates associated with sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2018;115:8209&#x2013;8214. doi: 10.1073/pnas.1801109115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1801109115</ArticleId><ArticleId IdType="pmc">PMC6094144</ArticleId><ArticleId IdType="pubmed">30038021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata H., Manfredi G. Different regulation of wild-type and mutant Cu,Zn superoxide dismutase localization in mammalian mitochondria. Hum. Mol. Genet. 2008;17:3303&#x2013;3317. doi: 10.1093/hmg/ddn226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn226</ArticleId><ArticleId IdType="pmc">PMC2566526</ArticleId><ArticleId IdType="pubmed">18703498</ArticleId></ArticleIdList></Reference><Reference><Citation>Varabyova A., Topf U., Kwiatkowska P., Wrobel L., Kaus-Drobek M., Chacinska A. Mia40 and MINOS act in parallel with Ccs1 in the biogenesis of mitochondrial Sod1. FEBS J. 2013;280:4943&#x2013;4959. doi: 10.1111/febs.12409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12409</ArticleId><ArticleId IdType="pubmed">23802566</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehvilainen P., Koistinaho J., Gundars G. Mechanisms of mutant SOD1 induced mitochondrial toxicity in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014;8:126. doi: 10.3389/fncel.2014.00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00126</ArticleId><ArticleId IdType="pmc">PMC4023018</ArticleId><ArticleId IdType="pubmed">24847211</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayvergiya C., Beal M.F., Buck J., Manfredi G. Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J. Neurosci. Off. J. Soc. Neurosci. 2005;25:2463&#x2013;2470. doi: 10.1523/JNEUROSCI.4385-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4385-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725162</ArticleId><ArticleId IdType="pubmed">15758154</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl F.U., Bracher A., Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature. 2011;475:324&#x2013;332. doi: 10.1038/nature10317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10317</ArticleId><ArticleId IdType="pubmed">21776078</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinder G.A., Lacourse M.C., Minotti S., Durham H.D. Mutant Cu/Zn-superoxide dismutase proteins have altered solubility and interact with heat shock/stress proteins in models of amyotrophic lateral sclerosis. J. Biol. Chem. 2001;276:12791&#x2013;12796. doi: 10.1074/jbc.M010759200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M010759200</ArticleId><ArticleId IdType="pubmed">11278741</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruening W., Roy J., Giasson B., Figlewicz D.A., Mushynski W.E., Durham H.D. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 1999;72:693&#x2013;699. doi: 10.1046/j.1471-4159.1999.0720693.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1999.0720693.x</ArticleId><ArticleId IdType="pubmed">9930742</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H., Kobayashi Y., Yoshihara T., Niwa J., Doyu M., Ohtsuka K., Sobue G. Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Res. 2002;949:11&#x2013;22. doi: 10.1016/S0006-8993(02)02568-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(02)02568-4</ArticleId><ArticleId IdType="pubmed">12213295</ArticleId></ArticleIdList></Reference><Reference><Citation>Okado-Matsumoto A., Fridovich I. Amyotrophic lateral sclerosis: A proposed mechanism. Proc. Natl. Acad. Sci. USA. 2002;99:9010&#x2013;9014. doi: 10.1073/pnas.132260399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.132260399</ArticleId><ArticleId IdType="pmc">PMC124414</ArticleId><ArticleId IdType="pubmed">12060716</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg S.J., Lyakhovetsky R., Werdiger A.C., Gitler A.D., Soen Y., Kaganovich D. Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc. Natl. Acad. Sci. USA. 2012;109:15811&#x2013;15816. doi: 10.1073/pnas.1205829109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1205829109</ArticleId><ArticleId IdType="pmc">PMC3465386</ArticleId><ArticleId IdType="pubmed">22967507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee B., Ahn Y., Kang S.M., Park Y., Jeon Y.J., Rho J.M., Kim S.W. Stoichiometric expression of mtHsp40 and mtHsp70 modulates mitochondrial morphology and cristae structure via Opa1L cleavage. Mol. Biol. Cell. 2015;26:2156&#x2013;2167. doi: 10.1091/mbc.E14-02-0762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E14-02-0762</ArticleId><ArticleId IdType="pmc">PMC4462935</ArticleId><ArticleId IdType="pubmed">25904328</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Yi J., Li X., Xiao Y., Dhakal K., Zhou J. ALS-associated mutation SOD1(G93A) leads to abnormal mitochondrial dynamics in osteocytes. Bone. 2018;106:126&#x2013;138. doi: 10.1016/j.bone.2017.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bone.2017.10.010</ArticleId><ArticleId IdType="pmc">PMC5718158</ArticleId><ArticleId IdType="pubmed">29030231</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>